Growth hormone antibodies formation in patients treated with recombinant human growth hormone

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 33-38

  Ahangari, G ^a   Ostadali, M R ^a   Rabani, A ^b   Rashidian, J ^a   Sanati, M H ^a   Zarindast, M R ^b  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dot blotting and antibody formation against recombinant drug; Enzyme linked immunosorbant assay (ELISA); Immunogenecity; Recombinant human growth hormone (rhGH)

Indexed keywords

GROWTH HORMONE ANTIBODY; HUMAN GROWTH HORMONE; NEUTRALIZING ANTIBODY; ALLOANTIBODY; RECOMBINANT PROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BODY GROWTH; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HYPOPHYSIS CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; ADULT; ANTIBODY COMBINING SITE; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; IMMUNOLOGY; NONPARAMETRIC TEST;

ADULT; BINDING SITES, ANTIBODY; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMAN GROWTH HORMONE; HUMANS; ISOANTIBODIES; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC;

EID: 5444246437     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700105     Document Type: Article

References (26)

1. Raben M. 1958. Treatment of pituitary dwarf with human growth hormone. J. Clin. Endocrinol. Metab, 18:901.
2. Preece M. A. 1986. Creutzfeld-Jakob disease: implications for growth hormone deficient children. Neuropathol. Appl. Neurobiol. 12:509.
3. Goddel V. H., L. Heyneker and T. Hozumi. 1979. Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone. Nature. 281:544.
4. Lewis U.J. 1992. Growth hormone. What is it and what does it do? Trends Endocrinol Metab. 3:117.
5. Kaplan S.L., L.E. Underwood, G.P. August, J.J. Bell, S.L. Blethen, R.M. Blizzard, D.R. Brown, T.P. Foley, R.L. Hintz, N.J. Hopwood, A. Johansen, R.T. Kirkland, L.P. Plotnick, R.G. Rosenfeld and J.J. Van Wyk. 1986. Clinical studies with recombinant DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet. 29:697.
6. Zwickel C.M., K.S. Cocke, R.N. Tamura, L.M. Holzhausen, G.T. Brophy, P.H. Bick and D. Wierda. 1991. Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkey. Fund. Appl. Toxicol. 16:275.
7. Milner R.D.G., N.D. Barnes, J.M.H. Buckler, D.I. Carson, D.R. Hadden, I.A. Hughes, D.I. Johnston, M.J. Parkin, D.A. Price, P.H.W. Rayner, D.C.L. Savage, M.O. Savage, C.S. Smith and P.G.F. Swift. 1987. United Kingdom multicentre clinical trial of Somatrem. Arch. Dis. Child. 62:776.
8. Strobl J. S and M. J. Thomas. 1994. Human growth hormone. Pharmacol. Rev. 46:1
9. Frasier S. D. 1983. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency. Endocrinol. Rev. 4:155.
10. Massa G.M., M. Vanderschueren-lodeweycky and R. Bouillon. 1993. Five- year follow-up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone. Clin. Endocrinol. 38:137.
11. Illig R., A. Prader, M. Ferrandez and M. Zachmann. 1971. Hereditary prenatal growth hormone deficiency with increased tendency to deficiency. Acta. Paediatr. Scand. 60:607.
12. Milner R.D.G and E.C. Burnes. 1982. Investigation of suspected growth deficiency. Arch. Dis. Child. 57:944.
13. Hashimoto Y., I. Ikeda, M. Ikeda, Y. Takahashi, M. Hosaka, H. Uchida, N. Kono, H. Fukui, T. Makino and M. Honjo. 1998. Construction of a specific and sensitive sandwich enzyme immunoassay for 20KD human growth hormone. J. Immunol. Meth. 221:77.
14. Becker G.W. and H.M. Hsiung 1986. Expression, secretion and folding of human growth hormone in Escherichia coli: purification and characterization. FEBS Lett. 204:145.
15. Zeisel H.J., A. Lutz and W. Von Petrykowski. 1992. Immunogenecity of a mammalian cell-derived recombinant human growth hormone preparation during long term treatment. Horm. Res. 37:47.
16. Moore W. 1978. The role of aggregated hGH in the therapy of hGH deficient children. J. Clin. Endocrinol. Metab. 46:20
17. Moore W. and P. Leppert. 1980. Role of aggregated human growth hormone (hGH) in development of antibodies to hGH in development of antibodies to hGH. J. Clin. Endocrinol. Metab. 51:691.
18. Illig R. 1970. Growth hormone antibodies in patients treated with different preparations of human growth hormone (hGH). J. Clin. Endocrinol. 31:697.
19. Underwood L.E., S.J. Voina and J.J. Wyk. 1974. Restoration of growth by human growth hormone (Roos) in hypopituitary dwarfs immunized by other human growth hormone preparations. Clinical and immunological studies. J. Clin Endocrinol. Metab. 38:288.
20. Eaton L.C. 1995. Host cell contaminant protein assay development for recombinant biopharmaceuticals. J. Chromatography 23:705.
21. Buzi F., C.R. Buchanan, D.J. Morrell and M.A. Preece. 1989. Antigenecity and efficacy of authentic sequence recombinant human growth hormone (Somatropin). First year experience in the United Kingdom. Clin. Endocrinol. 30:531.
22. Lebel J., A. Sediva, M. Snajderova, S. Pruhova and N. Rakosnikova. 2000. Immune system in adults with childhood-onset growth hormone deficiency: Effect of growth hormone therapy. Endocrine Regul. 34:169.
23. Preece M. A. 1986. Experience of treatment with pituitary derived human growth hormone with special reference to immunological aspects. In immunological aspects of human growth hormone. R.D.G. Milner & H. Flodh eds. Medical Education Services, Oxford University Press. Oxford, P. 9.
24. Tyllstrom J., B. Karlen and O. Guilbaud. 1986. Somatonorm (Somatrem): Immunological aspects of human growth hormone. R.D.G. Milner & H. Flodh eds. Medical Education Services, Oxford University Press. Oxford, p. 19.
25. He S.C., N. Qiao and W. Sheng. 2003. Neurobehavioral, autonomic nervous function and lymphocyte subsets among aluminum electrolytic workers. Int. J. Immunopathol. Pharmacol. 16:139.
26. Agostini M., B. Di Marco, G. Nocentini and D. V. Delfino. 2002. Oxidative stress and apoptosis in immune diseases. Int. J. Immunopathol. Pharmacol. 15:157.